About Pediatrix Medical Group, Inc. Common Stock (MD)
Pediatrix Medical Group Inc is a leading healthcare provider specializing in delivering pediatric healthcare services, with a primary focus on neonatal, maternal-fetal, and pediatric behavioral health care. The company operates through a network of highly skilled physicians and healthcare professionals, offering a range of services that include critical care for newborns, outpatient clinics, and specialty care initiatives aimed at improving health outcomes for children and their families. By integrating clinical excellence with compassionate care, Pediatrix aims to meet the unique needs of pediatric patients while also supporting their families throughout the healthcare process. Read More
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 4% year...
What Happened? Shares of pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) fell 6% in the afternoon session after the company reported a sharp ...
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 4% year...
Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.49 per share for the three months ended June 30, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.63.
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) will be reporting earnings this Tuesday before market open. Here’s what to look for. Pediatri...
Pediatrix Medical Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.3%. The stock now trades at $25.83, ma...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Pediatrix Medical Group, Inc. (NYSE: MD) (“Pediatrix” or “the Company”), a leading provider of physician services, today provided an update on its second quarter 2026 business trends.
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm infants, addressing pressing questions about one of the most controversial issues in the field of neonatology. The research was conducted by clinicians affiliated with the Pediatrix Center for Research, Education, Quality and Safety in collaboration with the NEC Society, utilizing data from the Pediatrix Clinical Data Warehouse (CDW), one of the largest databases of neonatal outcomes in the world. Data from the Pediatrix CDW has been utilized in more than 250 peer-reviewed publications.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Pediatrix Medical Group’s first quarter results surpassed Wall Street’s revenue and profit expectations, yet the market responded negatively, reflecting inve...
Pediatrix Medical Group (NYSE:MD) reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported by higher pricing, improved collections and continued strength in payer mix despite modest volume declines across its service lines.
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 3.9% year on...
